Shirai C, Sugai M, Komatsuzawa H, Ohta K, Yamakido M, Suginaka H
Department of Internal Medicine II, Hiroshima University School of Medicine, Japan.
Antimicrob Agents Chemother. 1998 May;42(5):1278-80. doi: 10.1128/AAC.42.5.1278.
Cibacron blue F3GA (CB) was found to reduce the MIC of oxacillin for methicillin-resistant Staphylococcus aureus (MRSA). This effect was not observed with methicillin-susceptible S. aureus. CB alters the resistance level of MRSA through a factor(s) other than mecA-related products, major autolysins, or femAB products. The exact target(s) of CB in causing the effect is unknown.
发现汽巴克隆蓝F3GA(CB)可降低耐甲氧西林金黄色葡萄球菌(MRSA)对苯唑西林的最低抑菌浓度(MIC)。而甲氧西林敏感的金黄色葡萄球菌未观察到这种效应。CB通过与mecA相关产物、主要自溶素或femAB产物不同的因素改变MRSA的耐药水平。CB产生这种效应的确切靶点尚不清楚。